RSRita Singhal

Rita Singhal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rita Singhal has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Beth Ann Glenn

    Department of Health Policy and Management, Fielding School of Public Health, UCLA Kaiser Permanente Center for Health Equity, University of California , Los Angeles

    3 shared publications
  • Roshan Bastani

    University of California, Los Angeles (UCLA), Los Angeles, USA

    3 shared publications
  • Christine H. Holschneider

    2 shared publications
  • L. Cindy Chang

    School of Public Health, UCLA Kaiser Permanente Center for Health Equity UCLA Fielding University of California, Los Angeles, Los Angeles, USA

    2 shared publications
  • Narissa J. Nonzee

    Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA 90095-6900, USA; UCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California, 650 Charles Young Drive South Drive, A2-125 CHS, Los Angeles, CA 90095-6900, USA

    2 shared publications
  • Victoria Mary Taylor

    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA

    2 shared publications

Latest Publications

  • Open Access

    Effectiveness and feasibility of three types of parent reminders to increase adolescent human papillomavirus (HPV) vaccination

    by Beth A. Glenn, Catherine M. Crespi, Alison K. Herrmann, Narissa J. Nonzee, Debra L. Rosen, Christine L. Park, Gina Johnson, L. Cindy Chang, Rita Singhal, Victoria M. Taylor, et al.


  • Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents

    by Narissa J. Nonzee, Susie B. Baldwin, Yan Cui, Rita Singhal


  • Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles

    by Beth A. Glenn, Jennifer Tsui, Rita Singhal, Leah Sanchez, Narissa J. Nonzee, L. Cindy Chang, Victoria M. Taylor, Roshan Bastani


  • Paradigm shifts

    by Erin Saleeby, Christine H. Holschneider, Rita Singhal

    Physicians have increasingly given up private practices to become members of, and key stakeholders in, large healthcare systems. These systems are currently transforming to meet the Triple Aim: guaranteeing the equitable provision of high-quality, evidence-based care at a reasonable cost. Participatory leadership is an organizational change theory that engages key stakeholders as architects in the transformation process. This review highlights the utility of this leadership strategy in designing care for women's health. Our blueprint describing participatory leadership theory in women's health systems change is discussed in three case studies, highlighting what we call the six Ps of participatory leadership: participants, principles, purpose, process, and power. The 'sixth P', product, can then be substantially influential in changing the paradigm of care. Obstetrics and gynecology is increasingly practiced in large health systems responsible for the health of populations. Innovations in clinical practice impact care at the level of the individual. In order for advances in clinical practice to reach broad populations of women, they must be integrated into a delivery system. Physician engagement in leadership during this time of system transformation is of critical importance.


    • 1 January 2011
      • Vol. 21  (4) , 495-501

    The impact of social communication on perceived HPV vaccine effectiveness in a low-income, minority population.

    by Alejandra Casillas, Rita Singhal, Jennifer Tsui, Beth A Glenn, Roshan Bastani, Carol M Mangione

    Perceived vaccine effectiveness is linked to vaccine-uptake. This study aims to determine if hearing about the HPV vaccine from family/friends (social source) or discussing the vaccine with family/friends (social discussion) is associated with perceived HPV vaccine effectiveness among female ethnic-minority, medical-decision-makers of vaccine-eligible girls. Data come from a cross-sectional HPV vaccine telephone-survey administered by the Los Angeles County Office of Women's Health (OWH) hotline operators between January-November 2009. Among survey participants who reported awareness of the HPV vaccine (n=294), two logistic regression models of perceived HPV vaccine effectiveness were conducted; a source of information model with social source as the main predictor, and a discussion model with social discussion as the main predictor. These were adjusted for medical source and medical discussion, and covariates affecting interaction with the health care system. Women who heard about the HPV vaccine from a social source were more likely to perceive the vaccine as effective compared to those who did not report a social source of information (adjusted OR 4.78, 95% CI 1.76-12.98). Medical source of information was also associated with perceived vaccine effectiveness (adjusted OR 2.07, 95% CI 1.06-4.05). Those who reported social discussion, but not those who discussed the vaccine with a medical provider, had increased odds of perceived vaccine effectiveness (adjusted OR 1.98, 95% CI 1.04-3.78). Social source of information and social discussion were associated with perceived HPV vaccine effectiveness; this highlights the value of social communication among low-income minority women, and the need for vaccine-messaging interventions that utilize a social network approach.(Ethn Dis. 2011;21(4):495-501)


  • Variations in Practice Guideline Adherence for Abnormal Cervical Cytology in a County Healthcare System

    by Rita Singhal, Lisa V. Rubenstein, Mingming Wang, Martin L. Lee, Anwar Raza, Christine H. Holschneider

    Background Reduction in cervical cancer incidence and mortality is not only dependant on promoting cervical cancer screening but also on providing appropriate follow-up and treatment of abnormal cervical cytology. Objectives The objective of this study was to determine variations in guideline adherence for women requiring abnormal cervical cytology follow-up. Subjects Subjects of the study are women 18 years or older with an abnormal Pap test in 2000 within a large county healthcare system (n = 8,571). Measurements Guideline adherence was determined by the presence or absence of the appropriate follow-up procedure within an acceptable time interval for each degree of cytological abnormality. Patients with no follow-up studies were deemed to be lost to follow-up. Results Of study subjects, 18.5% were lost to follow-up care. Of the remaining 6,987 women, 60.3% received optimal care, 9.4% received suboptimal care, and 30.3% received poor care. Follow-up rates were higher for patients with higher degree of cytological abnormality (OR, 1.29, 95% CI, 1.17–1.42), older patients (OR, 1.03, 95% CI, 1.02–1.030) and those receiving the index Pap test at a larger healthcare facility (OR, 1.13; 95% CI, 1.01–1.27). Receiving optimal care was positively correlated with higher degree of cytological abnormality (p < .0001) and larger facility size (p = .002). Regional variations in care demonstrated the largest cluster having the lowest lost to follow-up rate and the most optimal care. Conclusions A significant number of women with abnormal cervical cytology are receiving less than optimal care. Further studies are required to determine the specific healthcare delivery practices that need to be targeted to improve guideline adherence for follow-up of abnormal cytology.